Skip to content
Other

2'-Fucosyllactose

2'-fucosyllactose, abbreviated 2'-FL, is the most common oligosaccharide in human breast milk. It is approved as a novel food in the EU and produced industrially through fermentation.

2'-Fucosyllactose in our ingredient hub

Compare forms, amounts and prices from our own catalogue — unique product data, not a generic glossary page.

Open ingredient hub →

What an HMO is

Human milk oligosaccharide, HMO, is the collective term for a group of complex sugars found in breast milk. They are the third largest component after lactose and fat, with over two hundred identified variants. What is remarkable about them is that the infant cannot break them down — they pass through the small intestine largely intact.

Specifically 2'-FL

2'-fucosyllactose is the most common individual HMO in most women's breast milk. However, the level varies significantly between individuals and is controlled by the FUT2 gene. About one fifth of the European population carries a variant that results in very little or no 2'-FL production at all — in the literature, they are called non-secretors.

How it is produced

Commercial 2'-FL is not extracted from milk. It is produced through fermentation with genetically modified bacteria, usually E. coli strains engineered for this purpose, and then purified. The final product is chemically identical to that in breast milk.

Regulation

2'-fucosyllactose is approved as a novel food in the EU, with specified usage conditions and maximum levels for different food categories, including infant formula and dietary supplements. It is one of the few substances in this context with a formal EU approval. The approval pertains to its use — there is no approved health claim.

Adult market

Interest in HMOs as supplements for adults is newer than their use in infant formula, and the clinical literature on adults is consequently much thinner.

Related entries